Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy.

导出 OA

翻译打印收藏纠错

第一作者： Kyoko,Oura

第一单位： Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Kagawa, Japan.

作者： Kyoko,Oura ^[1] ; Asahiro,Morishita ^[1] ; Takushi,Manabe ^[1] ; Kei,Takuma ^[2] ; Mai,Nakahara ^[1] ; Tomoko,Tadokoro ^[1] ; Koji,Fujita ^[1] ; Shima,Mimura ^[1] ; Joji,Tani ^[1] ; Masafumi,Ono ^[1] ; Chikara,Ogawa ^[1] ; Akio,Moriya ^[2] ; Tomonori,Senoo ^[3] ; Akemi,Tsutsui ^[4] ; Takuya,Nagano ^[4] ; Koichi,Takaguchi ^[4] ; Takashi,Himoto ^[4] ; Tsutomu,Masaki ^[5]

作者单位： Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Kagawa, Japan. ^[1] Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Takamatsu 760-0017, Kagawa, Japan. ^[2] Department of Gastroenterology, Mitoyo General Hospital, Kanonji 769-1695, Kagawa, Japan. ^[3] Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu 760-8557, Kagawa, Japan. ^[4] Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu 761-0123, Kagawa, Japan. ^[5]

关键词 atezolizumab bevacizumab clinical outcome grip strength hepatocellular carcinoma immunotherapy overall survival psoas muscle sarcopenia skeletal muscle

DOI 10.3390/cancers15123243

PMID 37370853

发布时间 2023-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交